| pubmed-article:10796322 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10796322 | lifeskim:mentions | umls-concept:C0005064 | lld:lifeskim |
| pubmed-article:10796322 | lifeskim:mentions | umls-concept:C0543891 | lld:lifeskim |
| pubmed-article:10796322 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10796322 | pubmed:dateCreated | 2000-7-6 | lld:pubmed |
| pubmed-article:10796322 | pubmed:abstractText | Tardive dyskinesia (TD) is a potentially disfiguring movement disorder of the orofacial region often caused by use of neuroleptic drugs. A wide range of strategies have been used to help manage TD and, for those who are unable to have their antipsychotic medication stopped or substantially changed, the benzodiazapine group of drugs has been suggested as a useful adjunctive treatment. | lld:pubmed |
| pubmed-article:10796322 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10796322 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10796322 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10796322 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10796322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10796322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10796322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10796322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10796322 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10796322 | pubmed:issn | 1469-493X | lld:pubmed |
| pubmed-article:10796322 | pubmed:author | pubmed-author:McGrathJ JJJ | lld:pubmed |
| pubmed-article:10796322 | pubmed:author | pubmed-author:SoaresK VKV | lld:pubmed |
| pubmed-article:10796322 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:10796322 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10796322 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10796322 | pubmed:pagination | CD000205 | lld:pubmed |
| pubmed-article:10796322 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:10796322 | pubmed:meshHeading | pubmed-meshheading:10796322... | lld:pubmed |
| pubmed-article:10796322 | pubmed:meshHeading | pubmed-meshheading:10796322... | lld:pubmed |
| pubmed-article:10796322 | pubmed:meshHeading | pubmed-meshheading:10796322... | lld:pubmed |
| pubmed-article:10796322 | pubmed:meshHeading | pubmed-meshheading:10796322... | lld:pubmed |
| pubmed-article:10796322 | pubmed:meshHeading | pubmed-meshheading:10796322... | lld:pubmed |
| pubmed-article:10796322 | pubmed:meshHeading | pubmed-meshheading:10796322... | lld:pubmed |
| pubmed-article:10796322 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10796322 | pubmed:articleTitle | Benzodiazepines for neuroleptic-induced tardive dyskinesia. | lld:pubmed |
| pubmed-article:10796322 | pubmed:affiliation | Queensland Centre for Schizophrenia Research, Wolston Park Hospital, Brisbane, Queensland, Australia, Q4076. jjm@brain.wph.uq.oz.au | lld:pubmed |
| pubmed-article:10796322 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10796322 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10796322 | lld:pubmed |
